rs1562444 — MTNR1B MTNR1B 3'UTR Melatonin Signaling Variant

MTNR1B 3'UTR — A Regulatory Switch for the Melatonin-Glucose Clock

Your body runs on a 24-hour clock, and melatonin is its timekeeper. As darkness falls, melatonin rises — signaling sleep, lowering core body temperature, and, critically, telling your pancreatic beta cells to reduce insulin secretion until morning. The MTNR1B gene encodes the melatonin receptor type 2¹¹ melatonin receptor type 2
A G-protein-coupled receptor (MT2) expressed in the brain, retina, and — importantly — pancreatic beta cells, where it directly suppresses glucose-stimulated insulin release via inhibitory cAMP signaling (MT2) that mediates this signal in pancreatic beta cells.

The rs1562444 variant sits in the 3' untranslated region of MTNR1B — not in the protein-coding sequence, but in the regulatory tail of the gene's messenger RNA. This position places it within a region governing mRNA stability, turnover, and post- transcriptional control, including potential microRNA binding sites. Individuals carrying the G allele — the reference allele at this position, but the global minority allele (~44% worldwide, ~50% in Europeans) — show differences in circulating melatonin levels²² differences in circulating melatonin levels
Wang et al. 2019 (PMID 31815152) reported significant differences in plasma melatonin concentrations between rs1562444 genotypes compared to AA homozygotes, consistent with altered MTNR1B expression or signaling efficiency.

The Mechanism

Variants in the 3' UTR do not change the receptor protein itself but can alter how much MTNR1B is produced. This region contains AU-rich elements³³ AU-rich elements
Sequences in mRNA that govern degradation rate — more instability signals mean lower protein output that influence mRNA half-life and regulate microRNA binding. A single nucleotide change at position c.*371 (NM_005959.5:c.*371G>A) can shift the binding affinity of endogenous microRNAs or RNA-binding proteins that control MTNR1B transcript abundance.

More MTNR1B protein on beta cells means stronger melatonin-mediated suppression of cAMP and, therefore, reduced glucose-stimulated insulin secretion — particularly in the hours after sunset when melatonin is rising. The rs1562444 G allele appears to influence this expression level in the same direction as the well-established intronic risk variant rs10830963⁴⁴ rs10830963
The strongest GWAS hit for fasting glucose in the MTNR1B locus, present in 28% of Europeans, with P=3.2×10⁻⁵⁰ in the original discovery; already profiled separately in this encyclopedia, with which it shares partial linkage disequilibrium⁵⁵ linkage disequilibrium
A statistical tendency for nearby variants to be inherited together, meaning alleles at one site predict alleles at nearby sites within a population in the MTNR1B haplotype block.

The Evidence

The primary evidence for rs1562444 comes from several independent contexts. Wang et al. 2019⁶⁶ Wang et al. 2019
Wang P et al. Association of Melatonin Pathway Gene's Single-Nucleotide Polymorphisms with Systemic Lupus Erythematosus in a Chinese Population. J Immunol Res, 2019 genotyped 11 MTNR1B tag SNPs including rs1562444 in 495 SLE patients and 493 controls, reporting that rs1562444 genotype was associated with significant differences in plasma melatonin levels — direct biological evidence that this UTR variant modulates MTNR1B signaling output.

Robeva et al. 2023⁷⁷ Robeva et al. 2023
Robeva R et al. Melatonin Receptor 1B and Corticosteroid Receptor Polymorphisms in Infertile Women with Implantation Failure and Miscarriages. Front Biosci, 2023 found that G-allele- containing genotypes (AG+GG) were significantly enriched in 111 infertile women with recurrent implantation failure compared to 106 controls (19.3% vs. 3.6%, p=0.004), extending the MTNR1B signaling effect into reproductive physiology.

At the wider locus level, the landmark Prokopenko et al. 2009⁸⁸ Prokopenko et al. 2009
Prokopenko I et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet, 2009 and Bouatia-Naji et al. 2009⁹⁹ Bouatia-Naji et al. 2009
Bouatia-Naji N et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet, 2009 GWAS studies established that regulatory variation across the MTNR1B locus drives fasting glucose elevation (beta 0.06–0.07 mmol/L per risk allele) and type 2 diabetes risk (OR 1.09–1.15) in tens of thousands of Europeans.

Evidence for rs1562444's independent metabolic effect is emerging rather than established — its metabolic significance is partly inherited from its position within the MTNR1B haplotype block rather than from direct functional studies of this specific UTR position.

Practical Actions

The actionable guidance for MTNR1B G-allele carriers at rs1562444 mirrors the meal-timing interventions validated for the stronger intronic variants: eating earlier in the day, avoiding late dinners, and aligning meals with the low-melatonin window protect beta-cell function when melatonin receptor activity is elevated. Lopez-Minguez and Garaulet et al. 2018¹⁰¹⁰ Lopez-Minguez and Garaulet et al. 2018
Lopez-Minguez J et al. Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: a randomized, cross-over study. Clin Nutr, 2018 demonstrated in a randomized crossover trial that late dinner impairs glucose tolerance specifically in MTNR1B risk allele carriers.

Monitoring fasting glucose and HbA1c at recommended intervals provides the earliest warning if the metabolic effect begins to compound over time, especially for G-allele carriers who also eat late habitually.

Interactions

The MTNR1B locus contains several variants in partial LD that have been studied independently. The intronic rs10830963 (already profiled in Hormones & Sleep) is the strongest metabolic signal at this locus, while rs1562444 and the coding variant rs3781637 (G24E) represent additional dimensions of MTNR1B regulation. Co-carriage of rs1562444 G with the rs10830963 G risk haplotype could compound melatonin receptor overexpression in beta cells, though this specific interaction has not been formally modeled. Individuals carrying risk alleles at both rs1562444 and rs10830963 represent a subset worth considering for compound action guidance (see related SNP rs10830963 for the meal-timing intervention with the strongest published evidence).